399 related articles for article (PubMed ID: 15044465)
1. Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
Ueda Y; Wang S; Dumont N; Yi JY; Koh Y; Arteaga CL
J Biol Chem; 2004 Jun; 279(23):24505-13. PubMed ID: 15044465
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta.
Ungefroren H; Groth S; Ruhnke M; Kalthoff H; Fändrich F
J Biol Chem; 2005 Jan; 280(4):2644-52. PubMed ID: 15546867
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab.
Wang SE; Xiang B; Guix M; Olivares MG; Parker J; Chung CH; Pandiella A; Arteaga CL
Mol Cell Biol; 2008 Sep; 28(18):5605-20. PubMed ID: 18625725
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
[TBL] [Abstract][Full Text] [Related]
5. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity.
Bhowmick NA; Zent R; Ghiassi M; McDonnell M; Moses HL
J Biol Chem; 2001 Dec; 276(50):46707-13. PubMed ID: 11590169
[TBL] [Abstract][Full Text] [Related]
6. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
7. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
Park CY; Kim DK; Sheen YY
Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
Song K; Cornelius SC; Reiss M; Danielpour D
J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
[TBL] [Abstract][Full Text] [Related]
9. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation.
Blanchette F; Rivard N; Rudd P; Grondin F; Attisano L; Dubois CM
J Biol Chem; 2001 Sep; 276(36):33986-94. PubMed ID: 11448947
[TBL] [Abstract][Full Text] [Related]
11. HER2/Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor beta.
Wang SE; Shin I; Wu FY; Friedman DB; Arteaga CL
Cancer Res; 2006 Oct; 66(19):9591-600. PubMed ID: 17018616
[TBL] [Abstract][Full Text] [Related]
12. Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells.
Dumont N; Bakin AV; Arteaga CL
J Biol Chem; 2003 Jan; 278(5):3275-85. PubMed ID: 12421823
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells.
Watanabe H; de Caestecker MP; Yamada Y
J Biol Chem; 2001 Apr; 276(17):14466-73. PubMed ID: 11278290
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
Fanayan S; Firth SM; Butt AJ; Baxter RC
J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898
[TBL] [Abstract][Full Text] [Related]
15. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
Ammanamanchi S; Brattain MG
J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
Lu Y; Zi X; Zhao Y; Pollak M
Biochem Biophys Res Commun; 2004 Jan; 313(3):709-15. PubMed ID: 14697248
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA.
Edlund S; Landström M; Heldin CH; Aspenström P
Mol Biol Cell; 2002 Mar; 13(3):902-14. PubMed ID: 11907271
[TBL] [Abstract][Full Text] [Related]
18. Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase.
Groth S; Schulze M; Kalthoff H; Fändrich F; Ungefroren H
J Biol Chem; 2005 Sep; 280(39):33190-9. PubMed ID: 16051607
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of FXYD3 is induced by transforming growth factor-β signaling via ZEB1/δEF1 in human mammary epithelial cells.
Yamamoto H; Mukaisho K; Sugihara H; Hattori T; Asano S
Biol Pharm Bull; 2011; 34(3):324-9. PubMed ID: 21372379
[TBL] [Abstract][Full Text] [Related]
20. HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.
Wilson CA; Cajulis EE; Green JL; Olsen TM; Chung YA; Damore MA; Dering J; Calzone FJ; Slamon DJ
Breast Cancer Res; 2005; 7(6):R1058-79. PubMed ID: 16457687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]